MBL International Corp (MBLI)

Established in 1993, MBL International Corporation (MBLI) is a leading life science company focused on providing high quality, innovative, solutions-based products for both life science research and clinical diagnostics. Our products are used widely in academic research institutions, pharmaceutical and biotechnology companies, government agencies as well as hospital and reference laboratories.

MBLI develops, manufactures, and markets a broad portfolio of monoclonal and polyclonal antibodies, MHC tetramers, fluorescent and recombinant proteins and ELISA kits for research related to allergy, apoptosis, autophagy, cancer, epigenetics, immunology, and neuroscience.

In 2008, our diagnostic portfolio was extended with the acquisition of Bion Enterprises, Ltd adding an immunofluorence assay product line, further strengthening our autoimmune and infectious disease product offering.

We are committed to making your science more efficient and effective. From order to delivery and every point in between and after, we deliver uncompromising support through our scientific sales, customer service, and technical support teams to ensure that you get the product and assistance when you need it. Our extensive distribution network reaches out to over 50 countries so no matter where you are located our products and services are nearby.

Diagnostic Products for Autoimmunity & Infectious Disease
ELISA and IFA Detection Kits

MBL International is dedicated to providing the diagnostic marketplace with high quality diagnostic ELISA and IFA kits for the detection of autoimmune disease, viral and infectious diseases.

Research Products
Overview
Apoptosis
Autoimmune Disease
Autophagy & Proteolysis
Cancer & Cell Proliferation
Cell Culture
Cell Surface Antigens
Cellular Stress
Cytokines & Growth Factors
Epigenetics
Epitope Tags
Exosome Isolation
Fluorescent Proteins
GPCR
Inflammation & Immunology
Metabolism
Molecular Biology
Neuroscience
Signal Transduction
Solute Carrier
Virology
Tetramer